WHO Non-Lab-Based CVD Risk Assessment: A Reliable Measure in a North Indian Population

P Ananda Selva Das1,2, Mahasweta Dubey1,3, Ravneet Kaur1,4

  • 1Centre for Community Medicine, All India Institute of Medical Sciences, New Delhi, India.

Global Heart
|October 6, 2022
PubMed

Insights

This study found that World Health Organization (WHO) non-laboratory cardiovascular disease (CVD) risk charts accurately estimate CVD risk in rural India. These charts are suitable for resource-limited settings, aiding timely interventions.

Area of Science:

  • Cardiology
  • Public Health
  • Epidemiology

Background:

  • Cardiovascular diseases (CVD) pose a significant health burden globally.
  • Timely interventions for high-risk individuals, including those with high total CVD risk, can reduce heart attack and stroke incidence.
  • Accurate CVD risk prediction is crucial for identifying individuals who would benefit most from preventive strategies.

Purpose of the Study:

  • To determine the concordance between laboratory-based and non-laboratory-based World Health Organization (WHO) CVD risk charts.
  • To estimate the prevalence of key CVD risk factors in a rural Indian population.
  • To assess the suitability of non-laboratory CVD risk charts for resource-limited settings.

Main Methods:

  • A community-based cross-sectional study involving 1,018 participants aged 30-69 years in rural Ballabgarh, Haryana, India.
  • Data collection included the WHO STEPS questionnaire, anthropometry, and laboratory investigations for CVD risk factors.
  • Concordance analysis, including kappa statistics, was performed between laboratory and non-laboratory WHO CVD risk charts.

Main Results:

  • Hypertension (39.4%), overweight (34.1%), current smoking (23.6%), and hypercholesterolemia (18.7%) were prevalent CVD risk factors.
  • The agreement between laboratory- and non-laboratory-based charts was 83.3% (kappa = 0.64).
  • Non-laboratory charts demonstrated good sensitivity (86.5%) and specificity (90.3%) at a 5% risk cut-off compared to laboratory-based charts.

Conclusions:

  • There is good agreement between laboratory-based and non-laboratory-based WHO CVD risk charts.
  • Non-laboratory-based risk charts are suitable for estimating CVD risk in resource-limited settings like rural India.
  • These findings support the use of simplified risk assessment tools for CVD prevention in underserved populations.
Abstract

Related Concept Videos

Assessment of the Cardiovascular System I: Subjective Data01:23

Assessment of the Cardiovascular System I: Subjective Data

A thorough health history and physical assessment are essential for identifying cardiovascular disease (CVD) symptoms and distinguishing them from other health issues.
Initial Enquiry
Ask the patient about their primary concern and thoroughly explore all reported symptoms.
Medical History
Investigate past illnesses affecting the cardiovascular system, such as angina, anemia, rheumatic fever, congenital heart disease, stroke, thrombophlebitis, dysrhythmias, varicosities
Inquire about symptoms...
427
Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
285
Assessment of blood pressure in brachial artery(one-step method)01:15

Assessment of blood pressure in brachial artery(one-step method)

This procedural guide systematically measures blood pressure using an oscillometric digital sphygmomanometer, emphasizing accuracy, patient safety, and comfort.
Prepare for the Procedure:
675
Assessment of blood pressure in brachial artery(two-step method)01:23

Assessment of blood pressure in brachial artery(two-step method)

Measuring blood pressure is a fundamental skill in healthcare that aids in diagnosing and monitoring hypertension and other cardiovascular conditions. An aneroid sphygmomanometer, commonly used in clinical settings, offers a manual and precise method for blood pressure measurement. The technique for using this instrument involves specific steps that must be carefully executed to ensure accuracy. The following detailed description outlines a two-step technique for assessing blood pressure using...
846
Assessing Blood pressure in the Leg01:11

Assessing Blood pressure in the Leg

Proper measurement of leg blood pressure is a critical skill for healthcare providers, ensuring precise and reliable readings. When performed correctly, this procedure informs patient care and enhances the efficacy of interventions. The following text outlines step-by-step guidelines to measure blood pressure in the leg, providing clarity and ease of understanding for practitioners.
Preparation:
3.9K
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
189